<div xmlns="http://www.w3.org/1999/xhtml"><p>Human immunodeficiency virus (HIV) infection in children is common in resource limited settings [<a ref-type="bibr" href="#j_1905-7415.1003.482_ref_001_w2aab3b7ab1b6b1ab1b3b1Aa">1</a>]. If untreated, HIV infection causes progressive immunosuppression leading to opportunistic infections and other disorders. Most children infected with HIV progress to acquired immunodeficiency syndrome (AIDS) and die before the age of five [<a ref-type="bibr" href="#j_1905-7415.1003.482_ref_002_w2aab3b7ab1b6b1ab1b3b2Aa">2</a>, <a ref-type="bibr" href="#j_1905-7415.1003.482_ref_003_w2aab3b7ab1b6b1ab1b3b3Aa">3</a>]. Treatment of HIV-infected patients with effective, combination antiretroviral drugs can improve virologic, immunologic status and survival, by preventing or reversing immunosuppression [<a ref-type="bibr" href="#j_1905-7415.1003.482_ref_004_w2aab3b7ab1b6b1ab1b3b4Aa">4</a>, <a ref-type="bibr" href="#j_1905-7415.1003.482_ref_005_w2aab3b7ab1b6b1ab1b3b5Aa">5</a>]. Early diagnosis and prompt initiation of antiretroviral therapy (ART) in HIV-infected children remains a challenge. Failure of prompt initiation of ART is likely a major reason for high mortality rates seen in resource-limited settings [<a ref-type="bibr" href="#j_1905-7415.1003.482_ref_006_w2aab3b7ab1b6b1ab1b3b6Aa">6</a>].</p><p>Baseline severe anemia is common in developing countries. The causes of severe anemia are multiple. It is a condition that may cause delay in the initiation of therapy particularly when some of the early generation of inexpensive ART drugs such as zidovudine (azidothymidine or AZT) may also lead to anemia and neutropenia. Patients who receive a prescription for AZT should be counseled to contact their providers if they develop dyspnea on exertion or shortness of breath. A complete blood count should be conducted. Side effects with various other ART drugs are also common. Some of the side effects may improve with continued adherence. It is important for providers to understand the degree of seriousness of these adverse events and adjust the ART regimens for each HIV-infected child within the reality and limitations of local health systems [<a ref-type="bibr" href="#j_1905-7415.1003.482_ref_007_w2aab3b7ab1b6b1ab1b3b7Aa">7</a>]. It is also important for providers to inform caregivers of these HIV-infected children about various side effects. Caregivers should be encouraged to be vigilant in observing and reporting potential adverse drug reactions. Therefore, it is of paramount importance to develop a good partnership between providers and caregivers such that a good continuing adherence to various ART regimens for each child can be attained and immunosuppression averted leading to better health and quality of life within the limit of resources of a given context.</p><p>The article “HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes” published in this volume gives a snapshot of the situation of ART treatment of HIV-infected children in resource-limited settings [<a ref-type="bibr" href="#j_1905-7415.1003.482_ref_008_w2aab3b7ab1b6b1ab1b3b8Aa">8</a>]. The findings can serve as a reasonable baseline to mount a system leading to an early diagnosis, prompt treatment and adequate adherence to treatment stressing the importance of partnership of care between providers and caregivers of children infected with HIV.</p></div>

The importance of partnership for care of children infected with human immunodeficiency virus

Asian Biomedicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

The importance of partnership for care of children infected with human immunodeficiency virus

Article Category: Editorial

Published Online: Jan 31, 2017

Page range: 217 - 218

DOI: https://doi.org/10.5372/1905-7415.1003.482

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.